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Over a century ago, the zoologist Emile Maupas ﬁrst identiﬁed the nematode, Rhabditis elegans, in the soil in Algiers.
Subsequent work and phylogenic studies renamed the species Caenorhabditis elegans or more commonly referred to as
C. elegans; (Caeno meaning recent; rhabditis meaning rod; elegans meaning nice). However, it was not until 1963,
when Sydney Brenner, already successful from his work on DNA, RNA, and the genetic code, suggested the future of
biological research lay in model organisms. Brenner believed that biological research required a model system that could
grow in vast quantities in the lab, were cheap to maintain and had a simple body plan, and he chose the nematode C.
elegans to fulﬁll such a role. Since that time, C. elegans has emerged as one of the premiere model systems for aging
research. This paper reviews some initial identiﬁcation of mutants with altered lifespan with a focus on genetics and then
discusses advantages and disadvantages for using C. elegans as a model system to understand human aging. This review
focuses on molecular genetics aspects of this model organism.
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Introduction
In 1974, a little more than a decade after his ﬁrst thoughts
about working on a model organism, Brenner published
four manuscripts, including one entitled ‘The genetics of
Caenorhabditis elegans’(Brenner 1974) and a new ﬁeld
began. In this inﬂuential paper (Brenner 1974), Brenner
outlined methodology for isolation, complementation, and
mapping of worm mutants. Importantly, the publication
also included the successful isolation of several hundred
mutants affecting behavior and morphology, a discussion
of the number of deﬁned genes, and an estimation of
mutation frequency. Since that time, many discoveries
including dissection of programmed cell death (Coulson
et al. 1986; Ellis et al. 1991), the systematic cloning of
the genome (Coulson et al. 1986; Crawford 2001), the
deciphering of the entire DNA sequence (Consortium
1998), microRNAs (Lee et al. 1993; Reinhart et al. 2000),
RNA interference (Fire et al. 1998), and the use of GFP
(Chalﬁe et al. 1994) have been done in C. elegans which
has led to an expansion in the number of researchers
working with C. elegans.
C. elegans for aging research
For research on aging, early studies in C. elegans
focused on the feasibility of measuring lifespan and the
use of 5-Fluoro-2′-deoxyuridine (FUDR) to maintain
synchronous cultures of aged animals (Hosono 1978a,
1978b). In 1977, Klass (1977) published that C. elegans
was a good system for aging studies as he established a
method to consistently measure lifespan, and he con-
cluded that this could lead to future detailed analysis
combining genetics and biochemistry. In these early stud-
ies, Klass found that altering either temperature or the
amount of food resulted in a change in lifespan. In addi-
tion, only small effects on lifespan were observed based
on parental age or parental lifespan. Klass performed a
clonal genetic screen for mutants with altered lifespan
and identiﬁed ﬁve mutants (Klass 1983). Interestingly,
later genetic work on these mutants in the laboratory of
Tom Johnson, mapped all of them to a single genetic
locus, named age-1 (Friedman & Johnson 1988). This
was the ﬁrst breakthrough in aging research for studies
based on C. elegans as this study revealed that it was
possible to identify mutants that altered lifespan and
more importantly, individual genes could modulate
lifespan.
From the initial characterization of mutants that
altered lifespan, the words lifespan and aging have often
been used interchangeably. However, lifespan is a single
measureable parameter that deﬁnes the amount of time
an organism is alive but does not give any indication for
how an animal is actually aging. Lifespan as a measure-
ment gives little detail about the health of the animal.
For this reason, healthspan, deﬁned as the time that an
individual is active, productive and free from age-
associated disease, is starting to become the focus of
aging research (reviewed in (Tissenbaum 2012)).
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Equally important for aging research is the use of the
term regulation. Is aging regulated? Is lifespan regulated?
A regulated process should indicate that this is a trait
that would be selected for over time. However, ﬁtness
competitions between wild type and daf-2 mutants, show
that after four generations, none of the daf-2 mutants
remained primarily because of the early fertility defects
in the daf-2 mutants (Jenkins et al. 2004). Therefore,
similar to other studies with long-lived mutants and con-
sistent with the antagonistic pleiotropy theory of aging
(Lakowski & Hekimi 1996; Gems et al. 1998; Chen, Pan
et al. 2007; Chen, Senturk et al. 2007; Curran & Ruvkun
2007; Anderson et al. 2011), daf-2 mutants exhibit a
heavy ﬁtness cost with lifespan extension (Jenkins et al.
2004). Taken together, lifespan and aging should not be
used interchangeably and the use of the word regulation
should be monitored (reviewed in (Lithgow 2006;
Tissenbaum 2012)).
Several years after the age-1 gene was identiﬁed,
another gene was shown to modulate lifespan. Similar to
mutation in age-1, daf-2 mutants showed adult lifespan
extension (Kenyon et al. 1993). Interestingly, previously,
both daf-2 and age-1 had showed similarity based on a
different phenotype. Under favorable growth conditions,
C. elegans develop from an egg through four larval
stages (L1-L4) each separated by a molt, and then a ﬁnal
molt into a reproductive self-fertilizing adult hermaphro-
dite. In response to unfavorable growth conditions, in
particular, high levels of a secreted pheromone (i.e.
crowding, low food), worms can enter an alternative
developmental mode (at the L3 stage) forming dauer lar-
vae (Riddle & Albert 1997). Dauer (German for endur-
ing) larvae (alternate L3) maximize survival until
conditions become more favorable, whereupon they will
molt and form a reproductive adult. Genetic screens
identiﬁed mutants affecting the ability to enter this dauer
program. These mutants were named daf mutants indicat-
ing the dauer formation phenotype. Both daf-2 and
age-1 were initially isolated in this type of screen
because both daf-2 and age-1 (originally identiﬁed as
daf-23) mutants show a dauer constitutive (daf-c) pheno-
type such that even under good growth conditions,
mutants will enter the dauer stage (Albert et al. 1981).
Genetic epistasis analysis placed these two genes in a
similar genetic epistasis pathway for dauer formation that
was distinct from the other daf-c mutants (Vowels &
Thomas 1992). These studies also revealed that both daf-
2 and age-1 mutants could be suppressed by a mutation
in the daf-16 gene (Albert et al. 1981; Riddle 1988;
Vowels & Thomas 1992; Riddle & Albert 1997). daf-16
(also known as daf-17) was also isolated in these early
dauer formation genetic screens because daf-16 mutants
show a dauer defective (daf-d) phenotype such that even
under poor growth conditions, mutants will not enter the
dauer stage (Albert et al. 1981; Riddle 1988; Vowels &
Thomas 1992; Riddle & Albert 1997).
Subsequent molecular cloning beginning in 1996,
explained why these genes were separate and distinct
from other pathways. The genes encoded for members of
an insulin/IGF-1 signaling (IIS) pathway where daf-2
encoded for an IIS receptor, age-1 encoded for the cata-
lytic subunit of the PI 3-kinase, and daf-16 encoded for
a forkhead box O (FOXO) transcription factor down-
stream of the PI 3-kinase signaling cascade. Since then,
studies have shown that the IIS pathway is evolutionarily
conserved such that mutations in this pathway in ﬂies
and mice are also linked to lifespan extension (Barbieri
et al. 2003; Yen et al. 2011).
Molecular and genetic studies in Drosophila and C.
elegans have identiﬁed FOXO as a central regulator of
lifespan (Lin et al. 1997; Ogg et al. 1997; Giannakou
et al. 2004; Hwangbo et al. 2004). Modulation of Dro-
sophila FOXO (dFoxo) and C. elegans FOXO (daf-16)
dosage can either decrease or increase the lifespan of the
organism (Lin et al. 1997; Ogg et al. 1997; Giannakou
et al. 2004; Hwangbo et al. 2004). Importantly, advances
in genomic research have led to new ﬁndings in the area
of genome-wide association studies in humans. Multiple
human population studies have found an association
between single nucleotide polymorphisms (SNPs) in
human FOXO3 and human lifespan extension (Lunetta
et al. 2007; Willcox et al. 2008; Anselmi et al. 2009;
Flachsbart et al. 2009; Li et al. 2009; Soerensen et al.
2010; Zeng et al. 2010; Banasik et al. 2011; Malovini
et al. 2011), and the strength of the association appears
to increase with age (Flachsbart et al. 2009). Therefore,
FOXO3 has emerged as a candidate longevity gene in
humans. Taken together, just over a decade from the
molecular identiﬁcation of DAF-16 in C. elegans, multi-
ple studies have linked SNPs associated with human
DAF-16/FOXO3 and human lifespan extension.
Dauer and longevity connections
Early studies on dauer larvae showed that dauers were
‘ageless’; namely once a dauer recovers and develops
into a reproductive hermaphrodite, the subsequent adult
lifespan (post-dauer) is independent from the time spent
as a dauer (Klass & Hirsh 1976). Therefore, it was
thought that daf-2 and age-1 were long lived merely due
to activation of part of the dauer program manifested in
the adult. However, (Kenyon et al. 1993) addressed these
concerns by performing lifespan analyses on several
other daf-c mutants (later shown to be part of a TGF-β
signaling cascade) and found that these mutants did not
affect lifespan and the issue seemed resolved. However,
approaches including genome- wide microarrays and
unbiased LC/MS proteomics have shown that the proﬁles
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of adult long-lived daf-2 mutants are most similar to
wild-type dauer larvae (McElwee et al. 2004; McElwee
et al. 2006; Depuydt et al. 2014). Moreover, recent stud-
ies (Shaw et al. 2007) re-examined the TGF-β daf-c
mutants and found in contrast to earlier studies, these
mutants showed lifespan extension. Similarly, recent
genetic data revealed that the connections between the
IIS pathway and the TGF-β signaling pathway are inter-
twined to modulate both lifespan and dauer formation
(Narasimhan et al. 2011). Taken together, multiple stud-
ies suggest that the longevity of daf-2 mutants is due to
activation of the dauer program in the adult. Despite the
fact that a dauer program, an alternative hibernation state
to delay reproduction until growth conditions are favor-
able, seems worm speciﬁc, the signaling pathways that
were identiﬁed to regulate dauer formation modulate lon-
gevity from worms to mice, and are associated with
human longevity.
Advantages of worms
Why has C. elegans been used so successfully for aging
research? What would make an organism suitable for
aging research? As suggested by Sydney Brenner in
1963, the ability to easily and cheaply grow large quanti-
ties of worms in the lab is very helpful for aging
research, especially when identifying long-lived mutants.
C. elegans also have a relatively short lifespan (average
approximately 17 days at 20 °C), and the lifespan is lar-
gely invariant. The latter allows for identiﬁcation of
mutants that shorten or lengthen average lifespan by a
little as 10–15% and still be of statistical signiﬁcance.
Additional beneﬁts of using C. elegans include that the
entire genome is sequenced and annotated, the availabil-
ity of an RNAi library comprising approx. 80% of the
genes in the genome, the ease of generating transgenic
strains and the recent development of gene-targeting
approaches. This has allowed for extensive forward and
reverse genetic screens for genes that modulate lifespan.
The RNAi library allows RNAi to be done by feeding
worms bacteria that produce the desired dsRNA and then
either the worm or their progeny are scored for a longev-
ity phenotype (Ahringer 2006). Using genome-wide
RNAi feeding libraries, the importance of the mitochon-
dria, signal transduction, the response to stress, protein
translation, gene expression, and metabolism were found
to modulate lifespan (Dillin et al., 2002; Lee et al.,
2003; Hamilton et al. 2005; Hansen, Hsu et al. 2005;
Hansen, Taubert et al., 2007). Another advantage work-
ing with C. elegans for studying the aging process is that
the lifespan assay is straightforward, which allows for
large numbers of worms to be assayed in a single experi-
ment. Therefore, statistical signiﬁcance can be tested in
addition to the analysis of mortality rates. Together, these
techniques allow one to comprehensively survey the
worm genome for genes that modulate lifespan. This has
led to the identiﬁcation of more than 200 genes and regi-
mens that modulate lifespan in C. elegans and revealed
evolutionarily conserved pathways that modulate life-
span. Therefore, the combination of the short, invariant
lifespan, ease of assays, ample genetic, molecular and
genomic tools, and evolutionary conservation has
allowed C. elegans to develop into a premiere model
system for aging research.
Disadvantages of worms
Despite all the excellent advantages of working with C.
elegans for aging research, there are also several disad-
vantages for C. elegans as a model for human aging.
First, C. elegans have a simple body plan, and lack
many deﬁned organs/tissues including a brain, blood, a
deﬁned fat cell, internal organs, and is evolutionarily
distant from humans. Second, C. elegans are also only
1 mm in length which makes biochemistry more difﬁcult.
Typically, all biochemistry, microarray, immunoprecipita-
tion, and chromatin immunoprecipitation is performed on
whole worm extracts of either mixed-stage animals or
animals at a similar growth stage. This may lead to lim-
ited understanding of any tissue-speciﬁc signaling such
as whether a gene is expressed in the hypodermis or the
intestine. Finally, C. elegans cell culture is limited with
no system equivalent to Drosophila S2 cells.
Conclusion
C. elegans has proved to be an invaluable animal for
aging research. Thus far, research has focused on the use
of lifespan as a measurement of the aging process. These
studies have led to the identiﬁcation of hundreds of
genes and regimens that modulate lifespan. Although the
initial studies identiﬁed genes that altered lifespan and
affected dauer diapause, these signaling pathways have
nonetheless identiﬁed longevity-associated pathways
across phylogeny. However, to truly use C. elegans for
aging research, future studies should focus on under-
standing the connection between longevity and how an
animal ages, with a focus on health. Aging is much more
than a lifespan measurement. Aging involves the coordi-
nation of multiple systems in an organism and how they
change as a function of time. We should strive to use
model systems to reveal this systemic coordination on a
molecular and genetic level, and how this leads to
healthy aging rather than simply lifespan extension.
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